Aging
Navigate
100%
Figure 1
Figure 1.Proportion of HOPR stratified by dual antiplatelet therapy and CYP2C19 loss-of-function carrier status at 90±7 days. HOPR indicates high on-treatment platelet reactivity; ADP, adenosine diphosphate.